Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
JFL Life Sciences Ltd (JFLLIFE)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: JFLLIFE Pharmaceuticals & Drugs | Small Cap | JFL Life Sciences Share Price
BSE Share Price
Not Listed
Not Listed
JFL Life Sciences Ltd (JFLLIFE)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: JFLLIFE Pharmaceuticals & Drugs | Small Cap | JFL Life Sciences Share Price
BSE Share Price
Not Listed
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹34 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
54.8
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
60.14%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
67.47%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹33 Cr.
Face Value
₹10
All Time Low / High
₹0.00 / 0.00
Check Before You Invest
M-Cap below 100cr DeciZen not available
Is JFL Life Sciences Ltd a good quality company?
JFL Life Sciences Ltd is a quality company, based on a multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does JFL Life Sciences Ltd performance compare with that of its Peers?
Revenue growth of JFL Life Sciences Ltd vs industry peers?
JFL Life Sciences Ltd revenue CAGR is %, compared to the industry median CAGR of 12.65%, indicating slower growth and losing its market share.
Promoter shareholding and pledge status of JFL Life Sciences Ltd?
Promoters hold 67.47% of the JFL Life Sciences Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of JFL Life Sciences Ltd over the last decade?
Over the last 3 year(s), the stock has delivered a CAGR of -38.65% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
JFL Life Sciences Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 8.7% | 11.8% | 10.3% | 23.1% | 15.5% | 11.5% | 15.8% | 18.2% | - |
| Value Creation Index ⓘ | -0.4 | -0.2 | -0.3 | 0.7 | 0.1 | -0.2 | 0.1 | 0.3 | - |
Growth Parameters ⓘ |
|||||||||
| Sales ⓘ | 31.8 | 30.2 | 32.8 | 33.6 | 42.8 | 46.6 | 82 | 131 | 131 |
| Sales YoY Gr. | - | -5.1% | 8.6% | 2.5% | 27.5% | 8.7% | 76.2% | 60.1% | - |
| Adj EPS ⓘ | 0.2 | 0.2 | 0.3 | 1.2 | 0.9 | 1 | 1.3 | 1.9 | 2.1 |
| YoY Gr. | - | 22.2% | 27.3% | 314.3% | -26.7% | 17.7% | 26% | 54% | - |
| BVPS (₹) ⓘ | 3 | 3.3 | 3.6 | 4.7 | 9.8 | 10.8 | 12 | 13.9 | 14.2 |
| Adj Net Profit ⓘ | 0.3 | 0.4 | 0.5 | 2.8 | 2.8 | 3.3 | 4.2 | 6.4 | 7 |
| Cash Flow from Ops. ⓘ | -3 | 3.2 | -5.9 | 2.3 | -9.1 | 8.4 | -3.6 | -4.3 | - |
| Debt/CF from Ops. ⓘ | -2.8 | 2.9 | -2.9 | 6.8 | -0.8 | 0.7 | -3 | -5 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | 32% | 45.3% | 60.1% | ||||
| Adj EPS ⓘ | NA | 47.3% | 31.7% | 54% | ||||
| BVPSⓘ | NA | 31.4% | 12.4% | 16.2% | ||||
| Share Price | - | - | -38.7% | -21.4% | ||||
Key Financial Parameters ⓘ
| Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 6 | 6.9 | 8.8 | 30.6 | 12.9 | 9.7 | 11.1 | 15 | 14.6 |
| Op. Profit Mgn % ⓘ | 4.2 | 6.2 | 6.6 | 16 | 9.2 | 9.8 | 10 | 8.9 | 9.1 |
| Net Profit Mgn % ⓘ | 1 | 1.2 | 1.6 | 8.3 | 6.6 | 7.1 | 5.1 | 4.9 | 5.2 |
| Debt to Equity ⓘ | 1.7 | 1.7 | 2.5 | 1.4 | 0.2 | 0.2 | 0.3 | 0.5 | - |
| Working Cap Days ⓘ | 0 | 197 | 231 | 345 | 354 | 337 | 230 | 208 | 88 |
| Cash Conv. Cycle ⓘ | 0 | 103 | 108 | 172 | 182 | 213 | 148 | 130 | 37 |
Valuation of JFL Life Sciences - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
JFL Life Sciences Ltd FAQs
The current trading price of JFL Life Sciences on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of JFL Life Sciences stood at ₹34.48 Cr
The latest P/E ratio of JFL Life Sciences as of 31-Dec-1969 is 5.10.
The latest P/B ratio of JFL Life Sciences as of 31-Dec-1969 is 0.73.
The 52-week high of JFL Life Sciences is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of JFL Life Sciences is ₹131 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that JFL Life Sciences Ltd is a below average quality company.
The key valuation ratios of JFL Life Sciences Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of JFL Life Sciences Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About JFL Life Sciences Ltd
The Company was incorporated as ‘JFL Life Sciences Private Limited’ on April 25, 2010 as a private limited company under the Companies Act, 1956 with the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Pursuant to a special resolution of company’s Shareholders passed in the extra-ordinary general meeting held on February 10, 2022, the Company was converted from a private limited company to public limited company and consequently, the name of the Company was changed to ‘JFL Life Sciences Limited’, and a fresh certificate of incorporation dated March 3, 2022 was issued to the Company by the Registrar of Companies, Gujarat at Ahmedabad.
Headquartered in Ahmedabad, Gujarat, JFL Life Sciences is engaged in the business of manufacturing of pharmaceutical products. The company is engaged in domestic as well as international business. With market presence in PAN India, products of JFL is supplied to 10 developed and developing countries throughout the World. To maintain its competitiveness and to further the cause of health care JFL has laid a strong R&D foundation and a FDA approved state of the art manufacturing facility near Ahmedabad. It is a manufacturing company, so its sales strategy is to sell its products in bulk to pharmaceuticals marketers and traders who in turn provide the channel for sales to customers. It does not sell it under any brand name and it use the same strategy for both domestic & international market. The company exports its products majorly to African countries, Middle Eastern countries and CIS countries, mainly through merchant exporters. The company is registered with the MOH of Kenya, Nigeria, Yemen, Cambodia & Myanmar for manufacturing of a particular product. Few of its products are also registered with Ukraine, Uzbekistan, Kazakhstan (CIS countries) through merchants.
Business area of the company
JFL Life Sciences manufactures a wide range of pharmaceutical formulations. The company’s major products types are Dry powder injections; Tablets & Capsules (B-Lactam) solid oral dosage form; Tablet and capsules (General); and Oral Rehydration Solutions (ORS).
Major Events and Milestones
- 2010: The company was incorporated as a private limited company under the name JFL Life Sciences Private Limited.
- 2022: The company was converted from a private limited company to a public limited company and its name was changed to JFL Life Sciences Limited.
You have 46 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
